Pediatric Golden Cough-Relief Granules Approved, a Superior Clinical Solution for Acute Cough in Children

        GenSci Invites You to Meet Us at Arab Health 2025

        Chinese Monoclonal Anti-IL-1β Breakthrough: Acute Gout Arthritis Treatment Impresses at ACR 2024

        World ADC San Diego 2024: GenSci showcases two innovative pipeline programs

        Welcome to Visit Us at MEDICA 2024

        GenSci' s Inaugural R&D Day 2024: Innovation in Gene, Science in Action

        Meet GenSci at CPhI Milan 2024

        GenSci showcases the innovative pipelines at ChinaBio?

        GenSci Invites You to Meet Us at Pharmedi Vietnam 2024

        GenSci098 Injection Obtains Implied License For Clinical Trials of FDA

        Jintrolong? New Dosage Form of Long-acting Somatropin Injection Approved

        Clinical Trial Commencement of GenSci098 Injection Approved

        Zhejiang University – GenSci Joint Research Center of Children’s Health established

        NMPA: New Drug Application of Recombinant Human Follicle-Stimulating Hormone - CTP Fusion Protein Injection Accepted

        R&D Innovation Accelerator: Shanghai Children's Hospital and GenSci Ink Strategic Cooperation Agreement

        GenSci Invites you to join us in CPHI South East Asia 2024

        China's First Aqueous Solution Progesterone Injection, Jin Sai Xin? Approved

        GenSci and TWi Reach Exclusive Import and Distribution Agreement for Megaxia?

        Visit GenSci at CPhI China 2024

        NMPA Approves Genakumab Injection for Clinical Trial Commencement

        Jintrolong? PEG-SOMATROPIN from GenSci highlighted at ECE 2024

        R&D Progress: NMPA Approves Genakumab to the Market

        GenSci Launches Global Innovation Hub in Shanghai